# Expanded Access of Sotorasib

> **NCT04667234** · — · NO_LONGER_AVAILABLE · sponsor: **Amgen**

## Conditions studied

- Non Small-cell Lung Cancer
- Locally Advanced Unresectable NSCLC
- Locally Advanced Metastatic NSCLC

## Interventions

- **DRUG:** AMG 510

## Key facts

- **NCT ID:** NCT04667234
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04667234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04667234, "Expanded Access of Sotorasib". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04667234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*